Prostate Cancer
Research


Volume 1 Number 3
March 2013


Home > Disciplines > Publications > Prostate Cancer Research > Volume 1, Year 2013 > Number 3, March



CONTENTS


CASE REPORTS
DIAGNOSIS
FOLLOW-UP, QUALITY OF LIFE
INTEGRATIVE MEDICINE
PROGNOSIS
TREATMENT



CASE REPORTS

.

Pepe P, Fraggetta F, Tornabene F, Nicolosi M, Aragona F.
Solitary lung metastasis after radical prostatectomy in presence of undetectable PSA.
Arch Ital Urol Androl. 2012 Dec;84(4):208-10.
Source | Abstract | Similar articles



DIAGNOSIS

.

Chang SL, Harshman LC, Presti JC Jr.
Impact of common medications on serum total prostate-specific antigen levels: analysis of the National Health and Nutrition Examination Survey.
J Clin Oncol. 2010 Sep 1;28(25):3951-7. doi: 10.1200/JCO.2009.27.9406. Epub 2010 Aug 2.
Source | Full text | Similar articles



.

Panebianco V, Barchetti F, Sciarra A, Musio D, Forte V, Gentile V, Tombolini V, Catalano C.
Prostate cancer recurrence after radical prostatectomy: the role of 3-T diffusion imaging in multi-parametric magnetic resonance imaging.
Eur Radiol. 2013 Feb 2. DOI https://doi.org/10.1007/s00330-013-2768-3. [Epub ahead of print]
Source | Full text | Similar articles



.

Vickers A, Cronin A, Roobol M, Savage C, Peltola M, Pettersson K, Scardino PT, Schröder F, Lilja H.
Reducing unnecessary biopsy during prostate cancer screening using a four-kallikrein panel: an independent replication.
J Clin Oncol. 2010 May 20;28(15):2493-8. doi: 10.1200/JCO.2009.24.1968. Epub 2010 Apr 26.
Source | Full text | Similar articles



.

Wachter S, Tomek S, Kurtaran A, Wachter-Gerstner N, Djavan B, Becherer A, Mitterhauser M, Dobrozemsky G, Li S, Pötter R, Dudczak R, Kletter K.
11C-acetate positron emission tomography imaging and image fusion with computed tomography and magnetic resonance imaging in patients with recurrent prostate cancer.
J Clin Oncol. 2006 Jun 1;24(16):2513-9. DOI: 10.1200/JCO.2005.03.5279. Epub 2006 Apr 24.
Source | Full text | Similar articles



.

Xia J, Gulati R, Au M, Gore JL, Lin DW, Etzioni R.
Effects of screening on radical prostatectomy efficacy: the prostate cancer intervention versus observation trial.
J Natl Cancer Inst. 2013 Apr 17;105(8):546-50. doi: 10.1093/jnci/djt017. Epub 2013 Feb 14.
Source | Full text | Similar articles



FOLLOW-UP, QUALITY OF LIFE

.

Barry MJ, Gallagher PM, Skinner JS, Fowler FJ Jr.
Adverse effects of robotic-assisted laparoscopic versus open retropubic radical prostatectomy among a nationwide random sample of medicare-age men.
J Clin Oncol. 2012 Feb 10;30(5):513-8. doi: 10.1200/JCO.2011.36.8621. Epub 2012 Jan 3.
Source | Full text | Similar articles



.

Chen RC, Clark JA, Talcott JA.
Individualizing quality-of-life outcomes reporting: how localized prostate cancer treatments affect patients with different levels of baseline urinary, bowel, and sexual function.
J Clin Oncol. 2009 Aug 20;27(24):3916-22. doi: 10.1200/JCO.2008.18.6486. Epub 2009 Jul 20.
Source | Full text | Similar articles



.

Crook JM, Gomez-Iturriaga A, Wallace K, Ma C, Fung S, Alibhai S, Jewett M, Fleshner N.
Comparison of health-related quality of life 5 years after SPIRIT: Surgical Prostatectomy Versus Interstitial Radiation Intervention Trial.
J Clin Oncol. 2011 Feb 1;29(4):362-8. doi: 10.1200/JCO.2010.31.7305. Epub 2010 Dec 13.
Source | Full text | Similar articles



.

Ilic D, Hindson B, Duchesne G, Millar JL.
A randomised, double-blind, placebo-controlled trial of nightly sildenafil citrate to preserve erectile function after radiation treatment for prostate cancer.
J Med Imaging Radiat Oncol. 2013 Feb;57(1):81-8. doi: 10.1111/j.1754-9485.2012.02461.x. Epub 2012 Oct 18.
Source | Full text | Similar articles



.

Kimura M, Bañez LL, Polascik TJ, Bernal RM, Gerber L, Robertson CN, Donatucci CF, Moul JW.
Sexual bother and function after radical prostatectomy: predictors of sexual bother recovery in men despite persistent post-operative sexual dysfunction.
Andrology. 2013 Mar;1(2):256-61. doi: 10.1111/j.2047-2927.2012.00036.x. Epub 2012 Nov 29.
Source | Full text | Similar articles



.

Pardo Y, Guedea F, Aguiló F, Fernández P, Macías V, Mariño A, Hervás A, Herruzo I, Ortiz MJ, Ponce de León J, Craven-Bratle J, Suárez JF, Boladeras A, Pont À, Ayala A, Sancho G, Martínez E, Alonso J, Ferrer M.
Quality-of-life impact of primary treatments for localized prostate cancer in patients without hormonal treatment.
J Clin Oncol. 2010 Nov 1;28(31):4687-96. doi: 10.1200/JCO.2009.25.3245. Epub 2010 Oct 4.
Erratum in: J Clin Oncol. 2011 Feb 20;29(6):779.
Source | Full text | Erratum | Similar articles



.

Resnick MJ, Koyama T, Fan KH, Albertsen PC, Goodman M, Hamilton AS, Hoffman RM, Potosky AL, Stanford JL, Stroup AM, Van Horn RL, Penson DF.
Long-term functional outcomes after treatment for localized prostate cancer.
N Engl J Med. 2013 Jan 31;368(5):436-45. doi: 10.1056/NEJMoa1209978.
Source | Full text | Similar articles



.

Springer C, Inferrera A, Pini G, Mohammed N, Fornara P, Greco F.
Laparoscopic versus open bilateral intrafascial nerve-sparing radical prostatectomy after TUR-P for incidental prostate cancer: surgical outcomes and effect on postoperative urinary continence and sexual potency.
World J Urol. 2013 Feb 12. [Epub ahead of print]
Source | Full text | Similar articles



.

Sullivan JF, Stember DS, Deveci S, Akin-Olugbade Y, Mulhall JP.
Ejaculation profiles of men following radiation therapy for prostate cancer.
J Sex Med. 2013 May;10(5):1410-6. doi: 10.1111/jsm.12101. Epub 2013 Feb 22.
Source | Full text | Similar articles



INTEGRATIVE MEDICINE

.

Chao C, Williams SG, Xu L, Chen J, Wallner LP, Porter KR, Jacobsen SJ.
Statin therapy is not associated with prostate cancer recurrence among patients who underwent radiation therapy.
Cancer Lett. 2013 Feb 15. doi:pii: S0304-3835(13)00129-8. 10.1016/j.canlet.2013.02.017. [Epub ahead of print]
Source | Full text | Similar articles



PROGNOSIS

.

Abern MR, Aronson WJ, Terris MK, Kane CJ, Presti JC Jr, Amling CL, Freedland SJ.
Delayed radical prostatectomy for intermediate-risk prostate cancer is associated with biochemical recurrence: possible implications for active surveillance from the SEARCH database.
Prostate. 2013 Mar;73(4):409-17. doi: 10.1002/pros.22582. Epub 2012 Sep 19.
Source | Full text | Similar articles



.

Cooperberg MR, Hinotsu S, Namiki M, Ito K, Broering J, Carroll PR, Akaza H.
Risk assessment among prostate cancer patients receiving primary androgen deprivation therapy.
J Clin Oncol. 2009 Sep 10;27(26):4306-13. doi: 10.1200/JCO.2008.21.5228. Epub 2009 Aug 10.
Source | Full text | Similar articles



.

Eminaga O, Hinkelammert R, Titze U, Abbas M, Eltze E, Bettendorf O, Semjonow A.
The presence of positive surgical margins in patients with organ-confined prostate cancer results in biochemical recurrence at a similar rate to that in patients with extracapsular extension and PSA ≤ 10 ng/ml.
Urol Oncol. 2014 Jan;32(1):32.e17-25. doi: 10.1016/j.urolonc.2012.11.021. Epub 2013 Feb 19.
Source | Full text | Similar articles



.

Garzotto M, Beer TM, Hudson RG, Peters L, Hsieh YC, Barrera E, Klein T, Mori M.
Improved detection of prostate cancer using classification and regression tree analysis.
J Clin Oncol. 2005 Jul 1;23(19):4322-9. Epub 2005 Mar 21. DOI: 10.1200/JCO.2005.11.136
Source | Full text | Similar articles



.

Hashimoto T, Yoshioka K, Gondo T, Takeuchi H, Nakagami Y, Nakashima J, Tachibana M.
Predictors for positive surgical margins after robot-assisted radical prostatectomy: A single surgeon's series in Japan.
Int J Urol. 2013 Feb 19. doi: 10.1111/iju.12081. [Epub ahead of print]
Source | Full text | Similar articles



.

Nam RK, Toi A, Klotz LH, Trachtenberg J, Jewett MA, Appu S, Loblaw DA, Sugar L, Narod SA, Kattan MW.
Assessing individual risk for prostate cancer.
J Clin Oncol. 2007 Aug 20;25(24):3582-8. DOI: 10.1200/JCO.2007.10.6450
Source | Full text | Similar articles



.

Masuda H, Fukushima H, Kawakami S, Numao N, Fujii Y, Saito K, Koga F, Ishioka J, Yokoyama M, Kihara K.
Impact of advanced age on biochemical recurrence after radical prostatectomy in Japanese men according to pathological stage.
Jpn J Clin Oncol. 2013 Apr;43(4):410-6. doi: 10.1093/jjco/hyt017. Epub 2013 Feb 18.
Source | Full text | Similar articles



.

O'Brien MF, Cronin AM, Fearn PA, Smith B, Stasi J, Guillonneau B, Scardino PT, Eastham JA, Vickers AJ, Lilja H.
Pretreatment prostate-specific antigen (PSA) velocity and doubling time are associated with outcome but neither improves prediction of outcome beyond pretreatment PSA alone in patients treated with radical prostatectomy.
J Clin Oncol. 2009 Aug 1;27(22):3591-7. doi: 10.1200/JCO.2008.19.9794. Epub 2009 Jun 8.
Source | Full text | Similar articles



.

Shappley WV 3rd, Kenfield SA, Kasperzyk JL, Qiu W, Stampfer MJ, Sanda MG, Chan JM.
Prospective study of determinants and outcomes of deferred treatment or watchful waiting among men with prostate cancer in a nationwide cohort.
J Clin Oncol. 2009 Oct 20;27(30):4980-5. doi: 10.1200/JCO.2008.21.2613. Epub 2009 Aug 31.
Source | Full text | Similar articles



.

Stephenson AJ, Kattan MW, Eastham JA, Bianco FJ Jr, Yossepowitch O, Vickers AJ, Klein EA, Wood DP, Scardino PT.
Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era.
J Clin Oncol. 2009 Sep 10;27(26):4300-5. doi: 10.1200/JCO.2008.18.2501. Epub 2009 Jul 27.
Source | Full text | Similar articles



.

Zelefsky MJ, Eastham JA, Cronin AM, Fuks Z, Zhang Z, Yamada Y, Vickers A, Scardino PT.
Metastasis after radical prostatectomy or external beam radiotherapy for patients with clinically localized prostate cancer: a comparison of clinical cohorts adjusted for case mix.
J Clin Oncol. 2010 Mar 20;28(9):1508-13. doi: 10.1200/JCO.2009.22.2265. Epub 2010 Feb 16.
Source | Full text | Similar articles



TREATMENT

.

Mitsuzuka K, Koie T, Narita S, Kaiho Y, Yoneyama T, Kawamura S, Tochigi T, Ohyama C, Habuchi T, Arai Y.
Is pelvic lymph node dissection required at radical prostatectomy for low-risk prostate cancer?
Int J Urol. 2013 Feb 6. doi: 10.1111/iju.12112. [Epub ahead of print]
Source | Full text | Similar articles



.

Wilt TJ, Brawer MK, Jones KM, Barry MJ, Aronson WJ, Fox S, Gingrich JR, Wei JT, Gilhooly P, Grob BM, Nsouli I, Iyer P, Cartagena R, Snider G, Roehrborn C, Sharifi R, Blank W, Pandya P, Andriole GL, Culkin D, Wheeler T; Prostate Cancer Intervention versus Observation Trial (PIVOT) Study Group.
Radical prostatectomy versus observation for localized prostate cancer.
N Engl J Med. 2012 Jul 19;367(3):203-13. doi: 10.1056/NEJMoa1113162.
Erratum in: N Engl J Med. 2012 Aug 9;367(6):582.
Source | Full text | Erratum | Similar articles



bottom